← Leaderboards
Paul Guyre
Celdara Medical, Llc
$1,199,211
Attributed
$1,199,211
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $600K · FY2019–20$1M$750K$500K$250K$0
'19
'20
Funding mix
By agency
NIH$1,199,211 · 2
By mechanism
N43$1,199,211 · 2
Top collaborators
No co-investigators on record.
Most similar at Celdara Medical, Llc
Same institution · by research overlap
- Colleen Doyle Cooper$3,827,502
- Brandy Lynn Houser$1,127,804
Others in their field
Other Emerging Leaders on “Vaccines”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$149,372,007
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Ted Ross · University Of Georgia$71,962,304
Research focus
VaccinesMediatingAdjuvantAutoimmune DiseasesBloodBrugia MalayiBioinformatics ToolContractsEffector T CellEpitopesEvaluationHa AntigenHelminthsHuman ResourcesImmunityImmuneImmunogenicityImmunoregulationInfectionInfluenzaInfluenzavirusInfluenza Virus VaccineInsulin-Dependent Diabetes MellitusCells